Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-26

Clinical Trial Update: Use of Oxygen in Heart Failure With Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the use of oxygen in heart failure with preserved ejection fraction (HFpEF) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Heart Failure | Phase 2 | Status: COMPLETED